Novo Nordisk Inc

NJ · United States · Reporting entity ID 100000000144

Total reported 2019–2025

$263.0M

#50 of 2,960 reporting companies — 0.3% of all reported industry payments

$187.5M in general payments across 3,138,157 records, plus $75.5M in research funding across 4,101 records.

How it breaks down

General payments $187,504,537

Research funding $75,450,326

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.